Bio Filter Option
Morgan Lewis
  • Home
  • >
  • Brett A. Lovejoy, Ph.D.

Brett A. Lovejoy, Ph.D.

Partner

brett.lovejoy@morganlewis.com

San Francisco Phone +1.415.442.1211 Fax +1.415.442.1001

One Market, Spear Street Tower//San Francisco, CA 94105-1596//United States

Silicon Valley Phone +1.650.843.7576 Fax +1.650.843.4001

1400 Page Mill Road//Palo Alto, CA 94304-1124//United States

Brett Lovejoy writes and prosecutes, on a worldwide basis, patents directed to computer-implemented technologies, including life science applications making use of machine learning or artificial intelligence. He also has significant experience securing intellectual property protection for software, bioinformatics, diagnostics, digital health, quantum computing algorithms and hardware, medical and consumer devices, as well as chemistry, biochemistry, and renewable energy applications. When beneficial, Brett makes use of design patent law to protect client’s intellectual property, including fashion, sporting equipment, and devices (e.g., device casings).

Third parties have purchased many of the patents written by Brett, and others have been successfully enforced through litigation, or used as a basis for successful corporate fund raising.

Sample machine learning applications in the life sciences that Brett has worked on include application of support vector machines, neural networks, autoencoders, Markov chain models, tree-based algorithms, regression, and dimension reduction algorithms (e.g., principal component analysis, t-SNE).

Sample life science applications Brett has worked on include next generation DNA sequencing (including alignment, mapping, haplotyping and phasing), cancer classification, cancer detection, high throughput cell assays, and in silico high throughput screening (e.g., using molecular dynamics or convolutional neural networks, etc.) to name a few.

Prior to engaging in the practice of patent law in 1998, Brett worked as a researcher at UCLA, GlaxoSmithKline, and Roche, where he authored machine-learning software programs in various programming languages as part of his research. This work led to two first author Science publications on unrelated research: a Science article describing the X-ray crystal structure of an inhibitor bound to the active site of collagenase, and a Science report describing the X-ray crystal structure of a synthetic designer protein.

Awards and Affiliations

Member, Practice Group of the Year, Intellectual Property, Law360 (2019)

Member, Litigation Department of the Year–Intellectual Property, The American Lawyer (2019)

Admissions

  • California

Education

  • Santa Clara University School of Law, 2000, J.D.
  • University of California, Los Angeles, 1992, Ph.D. (Molecular Biology)
  • University of California, Santa Cruz, 1988, B.A. (Chemistry), With Honors

Sectors

  • Life Sciences
  • Technology
  • Digital Health

Services

  • Patent
  • Intellectual Property Litigation
  • Technology Transactions
  • Trademark Copyright Advertising Unfair Competition
  • Intellectual Property
  • Trade Secrets Proprietary Information Noncompetition Nondisclosure Agreements
  • Brand Product Innovation

Regions

  • North America

Events

1/12/2021 - Computer-Implemented Inventions in Biotechnology and Healthcare, Patentability from European and US Perspective

12/15/2020 - Focus: AI in Biotech

2/11/2020 - How Artificial Intelligence Is Transforming Early-Stage Biotech Partnerships & Drug Discovery

11/22/2019 - 2019 NIHA AI in Healthcare Forum: Policies and Regulations in Asia-Pacific

10/17/2019 - 2019 AAMA Healthcare Conference

10/11/2018 - 2018 AAMA Healthcare Conference

5/19/2016 - 2016 Technology May-rathon: Protecting Digital Health Intellectual Property

7/14/2015 - Strategies for Protecting Digital Health IP & The Big and Small of Protecting Molecules

News

4/2/2019 - Morgan Lewis Earns Top Rankings in Patexia Patent Prosecution Analysis

March 2018 - Morgan Lewis Among Juristat Top 100 Patent Firms in 2018

April 2017 - Morgan Lewis Recognized as a Top Patent Firm by Juristat

6/23/2016 - FDA Sets Its Sights On Silicon Valley’s Digital Health Boom

March 2016 - Morgan Lewis Ranked as one of Juristat's Top 100 Patent Firms

8/5/2015 - Morgan Lewis Advises Virtium in Growth Investment by L Squared Capital Partners

7/6/2011 - Morgan Lewis Further Enhances Life Sciences Practice with IP Partner in San Francisco focused on Bioinformatics

Publications

3/13/2019 - AI Is Hot, But Patent Hurdles Are High; What Does It Take To Win?, AI Business

October 2015 - An Update on Digital Health IP Protection, The Legal Intelligencer

10/19/2012 - Trade Dress, Copyright or Design Patent?, The Recorder